Skip to Content
Merck
  • Postmortem Determination of Short-Term Markers of Hyperglycemia for the Purposes of Medicolegal Opinions.

Postmortem Determination of Short-Term Markers of Hyperglycemia for the Purposes of Medicolegal Opinions.

Diagnostics (Basel, Switzerland) (2020-04-25)
Karolina Nowak, Tomasz Jurek, Marcin Zawadzki
ABSTRACT

Diabetes mellitus is classified as the epidemic of the 21st century. Due to the fact that acute carbohydrate metabolism disorders usually do not indicate morphological change, postmortem diagnosis is required to perform biochemical tests. The authors decided to evaluate the usefulness of determining glucose, lactate, acetone, β-hydroxybutyric acid (BHB), and 1,5-anhydroglucitol (1,5-AG) in postmortem blood/serum, urine, and vitreous humor (VH). Biological material was collected during autopsies. The study group consisted of 50 diabetics, while the control group consisted of 50 non-diabetics, who died a sudden death, with negative test results for the presence of ethyl alcohol and were not resuscitated before death. Statistical analysis was performed using the IBM SPSS Statistics 25 software package. The most statistically significant difference between the two groups was observed for mean 1,5-AG concentration. The authors found many correlations between the concentration of the examined markers in different materials, mainly between blood/serum and VH. The most suitable short-term glycemic marker in postmortem diagnosis is 1,5-AG. Diagnosis may be supported with determinations of acetone and BHB. For medicolegal assessment, the interpretation of the biochemical test results should comprise information on circumstances of death, medical history, results of other toxicological and histopathological tests, and autopsy report.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
N6-Cyclopentyladenosine, solid